scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12094-013-1007-3 |
P698 | PubMed publication ID | 23423807 |
P2093 | author name string | C Zhang | |
B Liu | |||
S Sun | |||
J Wei | |||
K-H Lee | |||
S Guan | |||
P2860 | cites work | Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma | Q73104080 |
Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India | Q73527255 | ||
Pathology of esophageal cancers: local experience and current insights | Q74568566 | ||
Autoantibodies in breast cancer: their use as an aid to early diagnosis | Q79905914 | ||
The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN | Q84192939 | ||
Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer | Q84945701 | ||
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
The inhibitory cytokine IL-35 contributes to regulatory T-cell function | Q28258462 | ||
Regulatory T cells and immune tolerance | Q29616864 | ||
Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma | Q33262742 | ||
Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma | Q33323321 | ||
Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma | Q34138855 | ||
Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas | Q34187865 | ||
Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). | Q34638359 | ||
Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma | Q34744973 | ||
Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells | Q34987934 | ||
Derangement of immune responses by myeloid suppressor cells | Q35573513 | ||
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays | Q36285345 | ||
Serum autoantibodies as biomarkers for early cancer detection | Q37622471 | ||
Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer? | Q51331951 | ||
A study of circulating anti-CD25 antibodies in non-small cell lung cancer. | Q54250692 | ||
A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. | Q55045567 | ||
Esophageal Cancer | Q56209683 | ||
Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
P433 | issue | 10 | |
P921 | main subject | biomarker | Q864574 |
esophageal squamous cell carcinoma | Q108442577 | ||
P304 | page(s) | 825-829 | |
P577 | publication date | 2013-02-20 | |
P1433 | published in | Clinical and Translational Oncology | Q15754324 |
P1476 | title | Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma | |
P478 | volume | 15 |
Q51364917 | A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer. |
Q55473534 | Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer. |
Q90318254 | Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma |
Q86360571 | Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma |
Q54382756 | Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer. |
Q26865552 | Esophageal cancer: Recent advances in screening, targeted therapy, and management |
Q91829072 | Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma |
Q36694379 | Further study of circulating IgG antibodies to CD25-derived peptide antigens in nonsmall cell lung cancer |
Q38272640 | Serum autoantibodies in the early detection of esophageal cancer: a systematic review |
Q45935803 | Study of circulating antibodies against CD25 and FOXP3 in breast cancer. |
Q34037876 | Use of autoantibodies to detect the onset of breast cancer |
Search more.